SURVEILLANCE AND LABORATORY DIAGNOSTICS OF INFECTIOUS DISEASES IN THE RUSSIAN FEDERATION I. DYATLOV

Similar documents
INSTITUT PASTEUR INSTITUT PASTEUR IS A PRIVATE, NON PROFIT, INSTITUTE DEDICATED TO RESEARCH & PUBLIC HEALTH

Selection and use of Ebola in vitro diagnostic (IVD) assays

Immunology (Advanced) (674M)

The need for mobile devices for rapid diagnosis of febrile or infectious diseases in resource-poor countries

13-III , ), N 45-III

Modeling Zoonoses to Identify Potential Vulnerabilities and Data Gaps: Rift Valley Fever in the United States

PACING Guide SY Timeline & Resources Q1 Lesson 1.1 The Mystery Infection

Unit title: Infectious Diseases

BWC/CONF.IV/4/Add.1 21 November Original: ENGLISH. Geneva, 25 November - 6 December 1996

Lawrence Livermore National Laboratory 2

MULTIECHELON DIAGNOSTICS (MEDx) TECHNOLOGY DEVELOPMENT AND TIERED EVALUATION

(As edited by the Law of the Republic of Belarus No. 397-Z of May 23, 2000

Session 3: Environmental Health Indicators

Published on Horizon 2020 ( Tuesday, 13 January, Ebola virus. Latest on Silver (September, 2015)

Course outlines for senior Microbiology and Virology units of study within the Bachelor of Medical Science Last updated 18 November 2006

Development of plasma therapies for emerging infectious diseases. Dr Glenn Smith Biological Science Section Scientific Evaluation Branch

UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES

The following is an overview of diagnostic techniques for Ebola infection in humans.

Molecular test to detect Dengue, Zika & Chikungunya and run on the QuRapID LV platform. Dr David Edge BioGene Dr Emily Adams LSTM

Health and Humanitarian Logistics. Richard J. Brennan, Director, Emergency Operations

Emergencies preparedness, response Ebola virus disease Democratic Republic

Chapter I. General Provisions

Working at Colindale, national and international projects, organisation. Pam Saunders

2. The first session concerned the scientific and technological aspects of infectious diseases and possible areas of activity.

Diagnostics: Learning from successful experiences which made it to market. Mark Miller, MD Chief Medical Officer biomérieux France

Emergencies preparedness, response Ebola virus disease Democratic Republic

Name: Ebola Epidemic: Student Worksheet

Near-Care Molecular Testing for Dengue, Zika, and Related Pathogens

Diagnostic Preparedness Platform WHO R&D Blueprint for Priority Infectious Diseases with Epidemic Potential

Ebola, Emergency Medicine, and Global Bioethics

NIAID Resources to Facilitate Medical Countermeasure Development

VECTOR CONTROL. Ms MA Groepe

Albert Camus, The Plague

TOPICS GENERAL BACTERIOLOGY

i) Wild animals: Those animals that do not live under human supervision or control and do not have their phenotype selected by humans.

Our Job: Prevent dis-ease as well as disease

3 4 December, Bangkok. Overview of IHR (2005)

Climate Change: The Public Health Response

The University of Jordan

Network of Aquaculture Centers in Central and Eastern Europe NACEE

Joint Project Manager Transformational Medical Technologies Advanced Planning Briefing for Industry

CHAPTER 24. Immunology

Syndromic Testing System

Chapter 1: Scope and History of Microbiology

Course outcomes. M.Sc Microbiology (CBCS) Code Course title Course Type HPW Credits

School of Allied Medical Sciences. Course Description Guide Associate in Medical Laboratory Sciences. Page 1 of 15

THE EUROPEAN BLOOD BANKING MARKET: France, Germany, Italy, Spain, UK Emerging Opportunities and Business Expansion Strategies.

VIROLOGY SERVICE OFFER

Diagnostic Microbiology

Role of an OIE Reference Laboratory Trichinellosis. Edoardo Pozio Istituto Superiore di Sanità Rome, Italy

Need of strengthening the well defined in- vivo Systems for pre-clinical evaluation of vaccines in India

EBOLA AND OTHER AFRICAN VIRAL HAEMORRHAGIC FEVERS

Introduction, by Tortora, Funke and Case, 11th Ed. TENTATIVE LECTURE OUTLINE DATE TOPIC CHAPTER

OIE Reference Laboratory Reports Activities

Countries in the WHO African

Role of DIAGNOSTICS in BIOPREPAREDNESS Mark Miller, MD Chief Medical Officer biomerieux

Ebola outbreak in West Africa : Shift in paradigm

MICROBIO, IMMUN, PATHOLOGY-MIP (MIP)

VIRUS INDEXING - A TECHNOLOGY FOR THE PRODUCTION OF QUALITY PLANTING MATERIAL IN BANANA

MEDICAL MICROBIOLOGY AND IMMUNOLOGY (M M & I)

Guide to Shipping Biological Materials

Working in a Microbiological Laboratory: face-to-face with infectious risk

Overview of Biologics Testing and Evaluation: Regulatory Requirements and Expectations. Audrey Chang, PhD, Senior Director Development Services

Learning through Doing Pilot Project Proposal. (Madagascar) Haleh Kootval Chief, Public Weather Services Programme WMO

Infectious Diseases. Bacteriology

Code and manual. Aquatic animals

Vector control. REGIONAL COMMITTEE Provisional Agenda item 8.4. SEA/RC70/10 Maldives 6 10 September July Seventieth Session

WHO Blood Regulators Network (BRN)

Lela Bakanidze, PhD. Georgian Biosafety Association (GeBSA) BACAC 3 rd Annual Conference, Tbilisi, September 28, 2011

How can companies be part of a development support program and humanitarian emergency response

Ebola Virus disease in West Africa : challenges and lessons learned

GMI: Global Microbial Identifier

Rapid Diagnostic Tests in Microbiology (PAs & PHs) I.Afeke UHAS

Growing Together: How Viruses Have Shaped Human Evolution. Shirlee Wohl Katherine Wu

Introduction to Lassa fever

Microbial Culture Collection of Cantacuzino Institute

Evidence that PCR diagnostics underestimate infection prevalence of Ichthyophonus in Yukon River Chinook salmon.

Viruses. Chapter 19. Biology Eighth Edition Neil Campbell and Jane Reece. PowerPoint Lecture Presentations for

Syllabus for BIO 310 Microbiology Lecture 3.0 Credit Hours Fall 2012

Criteria for Selection and Responsibilities of Regional Leading Laboratory

CDRH: Advancing Regulatory Science. Murray Malin, MD Center for Devices and Radiological Health March 29, 2011

GUIDANCE FOR INTERPRETATION OF PCR ASSAYS FOR VEROCYTOTOXIGENIC

YELLOW FEVER DIAGNOSIS IN OUTBREAK CONTEXTS: CHALLENGES AND LIMITATIONS

EDCTP perspective on biopreparedness and related capacity development in Africa

BIOLOGICAL BASIS OF PUBLIC HEALTH BMS505, Fall 2012 Syllabus

EXECUTIVE SUMMARY EXECUTIVE SUMMARY. Global funding for neglected disease R&D increased for the first time since The survey.

Viral Haemorrhagic Fevers. Major Dan Burns Infectious Diseases Registrar

Public private partnerships

Course Description Guide

BATTLING BUGS: INROADS IN INFECTIOUS DISEASES

The University of Jordan Accreditation & Quality Assurance Center Course Syllabus Course Name:

Laboratory Research Conduct & Safety: Biohazards and Biosafety. Environmental Health & Safety

ENDOSCOPE REPROCESSING AND INFECTION CONTROL FOR ENDOSCOPY

GhazalaRubi. F.I.B.M.S; MPhil(Mol.Bio) PhD (Human Genetics & Mol.Bio)

S Y LLAB US of t h e M O DULE (SUBJECT) G e n e r a l I n f o r m a t i o n. II; spring; III; winter

Genomics and its Impact on Diagnostic Microbiology

World Congress on Infectious Diseases & Vaccines About the Conference: Aim Target Audience Conference Highlights

Quest Diagnostics and QIAGEN Relationship. Michael A. Lewinski, Ph.D., D(ABMM) Director, Infectious Diseases Quest Diagnostics Nichols Institute

Objectives. At the end of the presentation we will be able to:

Vision 2015 for Veterinary Medicines within the framework of the ETPGAH. Declan O Brien, Chairman, Executive Board, ETPGAH

Transcription:

SURVEILLANCE AND LABORATORY DIAGNOSTICS OF INFECTIOUS DISEASES IN THE RUSSIAN FEDERATION FEDERAL SERVICE OF SURVAILLANCE IN THE FIELD OF CONSUMER RIGHT PROTECTION & HUMAN WELFARE, RUSSIA I. DYATLOV

Russia priorities of the international cooperation G8 decisions on the infectious diseases control (Russia, 2006; Germany, 2007; Japan, 2008 г) Obligations on of the international medicosanitary rules (2005) Activity within the framework of the WHO European office Program of cooperation in the field of sanitary protection of territories of states-participants of the CIS from import and distribution of especially dangerous infections Cooperation with other international organizations 2

G8 decisions on infectious diseases control (Russia,2006) International Med-Sanitary rules coming into force (2005) STRATEGY AND TACTICS OF INFECTIOUS DISEASES CONTROL 3

Global strategy of infectious diseases control 1 2 3 Application of modern information, forecastmodelling, monitoring, diagnostic, preventive, industry technologies and system of a professional training Creation and maintenance of the technological basis for the prevention, early revealing, operative reaction and liquidation of biological incidents Development of organizational, methodical, tactical, legal questions 4

Russia tactics on realization of decisions of Summit and IHR (2005) Strengthening Strengthening of of material material base base of of Stationary Stationary laboratory laboratory networks networks of of the the State State sanitary sanitary epidemiological epidemiological surveillance surveillance system system Mobile Mobile specialized specialized antiepidemic antiepidemic brigades brigades modernization modernization 5

The infectious (parasitic) diseases demanding carrying out of actions on sanitary protection of Russia Nosological form Smallpox The poliomyelitis caused by the wild polyovirus The human flu caused by a new subtype Heavy sharp respiratory syndrome Cholera Plague Yellow fever Lass fever Disease, caused by a Marburg virus Disease, caused by a Ebola virus Malaria Western Nile Fever Crimea-Congo hemorrhagic fever Dengue fever Rift Valley Fever Meningitis 6

Laboratory tests of human and environmental materials to identify dangerous infectins There are 69 laboratories to diagnose especially dangerous infectious diseases in Russia. They are based in the of Hygiene and epidemiology centers (Rospotrebnadzor). Year The number of tests 2005 657 947 2006 691 376 2007 750 000 7

Organizational, scientific and material strengthening of a national laboratory network Introduction Introduction in in practice practice of of the the technologies technologies based based on on the the causative causative agent` agent` genome genome and and proteome proteome analysis, analysis, multiplex, multiplex, microvolumetric microvolumetric methods methods Diagnostic, Diagnostic, prophylaxis prophylaxis and and treatment treatment methods methods and and means means based based on on nanotechnologies nanotechnologies and and nanomaterials, nanomaterials, introduction introduction in in practice practice of of public public health health services services 8

Laboratory network for indication, specific diagnostics, typing and monitoring of dangerous infectious (parasitic) causative agents Regional Regional centers centers on on monitoring monitoring of of infectious infectious and and parasitic parasitic diseases` diseases` causative causative agents agents I-IV I-IV groups groups of of pathogenicity pathogenicity (Russian (Russian classification) classification) Centers Centers of of indication indication and and diagnostics diagnostics in in Federal Federal districts districts of of Russia Russia Reference-centers Reference-centers on on causative causative agents agents monitoring monitoring in in IHR IHR frameworks frameworks (2005) (2005) National National centers centers of of diagnostic diagnostic activity activity verification verification 9

7 Regional centers on monitoring of infectious and parasitic disease causative agents II-IV groups of pathogenicity (Russian classification) 19 Regional centers on monitoring of infectious and parasitic disease causative agents I-II groups of pathogenicity (Russian classification) FUNCTIONS Bacteriological, virologic, serologic, parasitologic, moleculargenetic assays Study of etiological factors of infectious and parasitic diseases 10

8 centers of indication and diagnostics of causative agents based on anti-plague institutions FUNCTIONS Indication and diagnostics of dangerous infectious diseases (bacterial and virus) Study of etiological factor to prevent or to liquidate extreme situations METHODS Express-diagnostic (MFA, bacterioscopy) Speed diagnostic (PCR, ELISA, serologic reaction) Full bacteriological analysis 11

17 Reference-centers on causative agents monitoring in IHR frameworks (2005) based on research institutions FUNCTIONS Advisory and practical help to health care establishments and services; Identification and study of biological, molecular-genetic, biochemical characteristics of causative agents of infectious and parasitic diseases; Detection of cultures with atypical properties; New agents detection 12

4 national centers of diagnostic activity verification based on epidemiology and microbiology research institutions FUNCTIONS Verification of results of diagnostics carried out by the Centers of indication and diagnostics Identification of dangerous infectious causative agents diseases of unknown etiology with heavy symptoms Molecular-epidemiology analysis Study of virologic, bacteriological, molecular-biological, serological, immunochemical properties of especially dangerous causative agents 13

4 National centers as state collections Collection Collection Safety Safety Maintenance Maintenance (I-II (I-II groups groups of of pathogenicity) pathogenicity) Antiterrorist Antiterrorist security security Modern Modern access access control control and and storage storage equipment equipment Increase Increase of of reliability reliability and and storages storages terms terms of of microbe microbe cultures cultures Maintenance Maintenance of of the the basic basic biological biological properties properties of of microorganisms microorganisms Strain Strain certification certification and and databases databases creation creation 14

Federal Target Program «National system of chemical and biological safety of the Russian Federation (2009-2013 )» Government Russian Decision (Ocrober 27, 2008, No. 791) The Government of the Russian Federation decides: 1. To ratify the applied federal target program " National system of chemical and biological safety of the Russian Federation (2009-2013)". PURPOSE OF THE PROGRAM Consecutive decrease of influence of dangerous biological factors on the population, biosphere, technosphere and ecological systems to a comprehensible risk level 15

Federal Target Program «National system of chemical and biological safety of the Russian Federation (2009-2013 )» PRIORITY DIRECTIONS OF THE PROGRAM Current situation analysis, coordination of involved agencies` interaction Strengthening of material base of the organizations which are carrying out the control (supervision) and monitoring Analysis of Russian methodical base on the biological safety, scientific substantiation on its perfection Risk reduction from biological danger sources for population health for environment Development of uniform scientific-methodical approaches, technologies and protection means against influence of dangerous biological factors Increase of the level of knowledge of the population, a professional training, creation of risks management tools 16

Development of GIS-technologies and forecast-modelling systems for estimation of biological danger of especially dangerous infections epidemics Electronic Electronic maps maps for for carrying carrying out out of of monitoring monitoring Databases Databases with with geographical geographical binding binding Agents Agents monitoring monitoring Mathematical Mathematical model model and and the the program program of of Russian Russian territories territories differentiation differentiation on on epidemic epidemic danger danger degree degree Russia Russia territory territory typification typificationon on nosologic nosologicforms of of diseases diseases 17

Russian Federation - the donor of the international help to public health services of the countries with insufficient resources $ 32 mln. Russian contribute to the Global Fund (2006 2007); $ 20 mln. Russian contribute to the program on combating malaria in Africa (2006); $ 1,8 bln. Russia planned contribute to AIDS and Viral Hepatitis Program (2006 2010); $ 217 mln. intended previously for fninancing projects in Russia will be backed to the Global Fund in 2006 According official G8 Summit web- site 18